Achieve Life Sciences, Inc.ACHVNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +62.61% | +63.05% | +38.47% | +1.07% | +0.96% |
| Weighted Average Shares Diluted Growth | +62.61% | +63.05% | +38.47% | +1.07% | +0.96% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +96.89% | +99.44% | -60.93% | -9.04% | +8.60% |
| Book Value per Share Growth | +377.87% | +0.00% | -84.99% | -2.50% | +6.11% |
| Debt Growth | -39.52% | -40.48% | -42.07% | -43.55% | +1.15% |
| R&D Expense Growth | +112.48% | +245.13% | +153.55% | +31.18% | -30.08% |
| SG&A Expenses Growth | +68.00% | +115.40% | +82.12% | +76.49% | +92.96% |